N. S. Kokanov, “RASSF1A and p16 promoter methylation and treatment response in chronic hepatitis C genotype 1b patients treated with pegylated interferon/ribavirin”, Arch Biol Sci, vol. 74, no. 1, pp. 57–66, Apr. 2022.